The present invention relates to specific sphingolipids/sphingolipid derivatives as pharmaceutical compositions as well as their use in the preparation of medicaments for the treatment, prevention and/or amelioration of disorders relating to pathological processes in lipid rafts.

 
Web www.patentalert.com

< Use of tellurium containing compounds as nerve protecting agents

> Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus

> NF-.kappa.B activating gene

~ 00565